#glp-1-obesity-drugs

[ follow ]
#weight-loss-pharmaceuticals #behavioral-health-integration #noom-med-launch #digital-health-expansion
Medicine
fromFortune
5 days ago

Health startup Noom is now adding weight loss injectables to its offerings, says 'outcomes are so much better' | Fortune

Noom launches Noom Med, combining GLP-1 obesity drugs like Wegovy with behavioral coaching for $120 monthly, joining competitors capitalizing on highly effective weight-loss medications.
from24/7 Wall St.
5 months ago

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (Sept 2025)

With as much as $17 billion in sales in 2024 and over $10 billion in the first half of 2025, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo Nordisk A/S ( NYSE: NVO). This Scandinavian economic behemoth is one of the highest-valued companies in Europe at over $500 billion, which exceeds Denmark's entire gross domestic product.
Business
fromBloomberglaw
6 months ago

FDA Chief Says Hims' Weight-Loss Drug Ad Breached Agency's Rules

"Online pharmacies are advertising drugs with only upsides mentioned, contributing to America's culture of overreliance on pharmaceuticals for health," Makary wrote in a JAMA Network Open article focused on how the agency is overdue for a "crackdown on misleading pharmaceutical advertisements."
Public health
[ Load more ]